TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study

Hilary Coon, Nanda Singh, Diane Dunn, John H. Eckfeldt, Michael A. Province, Paul N. Hopkins, Robert Weiss, Steven Hunt, Mark F. Leppert

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Familial combined hyperlipidemia (FCHL) is the most common familial dyslipidemia, and is implicated in up to 20% of cases of premature coronary heart disease. Positive linkage to chromosome 1q was found in FCHL families participating in the NHLBI Family Heart Study (FHS), replicating linkage found in other studies. The HcB-19 mouse, which shares phenotypes with FCHL, was shown in other studies to have a nonsense mutation in the thioredoxin interacting protein gene (txnip). txnip is a gene on mouse chromosome 3 in a region syntenic with the 1q human FCHL linkage region. We re-sequenced the human homolog of mouse txnip in the FHS sample and identified nine single nucleotide polymorphisms (SNPs). We did not observe the nonsense mutation found in the HcB-19 mouse, and only three of the SNPs discovered were sufficiently polymorphic for analysis. No association between FCHL and the TXNIP gene was found. Within FCHL cases, presence of variants also did not significantly affect body mass index or levels of lipids, insulin, or glucose. Our results suggest that in this sample, TXNIP does not play a major role in FCHL or related traits, and is unlikely to account for the positive evidence of linkage in this region.

Original languageEnglish
Pages (from-to)357-362
Number of pages6
JournalAtherosclerosis
Volume174
Issue number2
DOIs
Publication statusPublished - Jun 2004
Externally publishedYes

Fingerprint

Familial Combined Hyperlipidemia
National Heart, Lung, and Blood Institute (U.S.)
Genes
Thioredoxins
Nonsense Codon
Single Nucleotide Polymorphism
Chromosomes, Human, Pair 3
Dyslipidemias
Coronary Disease
Proteins
Body Mass Index
Chromosomes
Insulin
Phenotype
Lipids
Glucose

Keywords

  • Association
  • FCHL
  • Hyperlipidemia
  • Linkage
  • TXNIP

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Coon, H., Singh, N., Dunn, D., Eckfeldt, J. H., Province, M. A., Hopkins, P. N., ... Leppert, M. F. (2004). TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study. Atherosclerosis, 174(2), 357-362. https://doi.org/10.1016/j.atherosclerosis.2004.02.004

TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study. / Coon, Hilary; Singh, Nanda; Dunn, Diane; Eckfeldt, John H.; Province, Michael A.; Hopkins, Paul N.; Weiss, Robert; Hunt, Steven; Leppert, Mark F.

In: Atherosclerosis, Vol. 174, No. 2, 06.2004, p. 357-362.

Research output: Contribution to journalArticle

Coon, H, Singh, N, Dunn, D, Eckfeldt, JH, Province, MA, Hopkins, PN, Weiss, R, Hunt, S & Leppert, MF 2004, 'TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study', Atherosclerosis, vol. 174, no. 2, pp. 357-362. https://doi.org/10.1016/j.atherosclerosis.2004.02.004
Coon, Hilary ; Singh, Nanda ; Dunn, Diane ; Eckfeldt, John H. ; Province, Michael A. ; Hopkins, Paul N. ; Weiss, Robert ; Hunt, Steven ; Leppert, Mark F. / TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study. In: Atherosclerosis. 2004 ; Vol. 174, No. 2. pp. 357-362.
@article{33842092b5d94fce8de19e4be5669b2e,
title = "TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study",
abstract = "Familial combined hyperlipidemia (FCHL) is the most common familial dyslipidemia, and is implicated in up to 20{\%} of cases of premature coronary heart disease. Positive linkage to chromosome 1q was found in FCHL families participating in the NHLBI Family Heart Study (FHS), replicating linkage found in other studies. The HcB-19 mouse, which shares phenotypes with FCHL, was shown in other studies to have a nonsense mutation in the thioredoxin interacting protein gene (txnip). txnip is a gene on mouse chromosome 3 in a region syntenic with the 1q human FCHL linkage region. We re-sequenced the human homolog of mouse txnip in the FHS sample and identified nine single nucleotide polymorphisms (SNPs). We did not observe the nonsense mutation found in the HcB-19 mouse, and only three of the SNPs discovered were sufficiently polymorphic for analysis. No association between FCHL and the TXNIP gene was found. Within FCHL cases, presence of variants also did not significantly affect body mass index or levels of lipids, insulin, or glucose. Our results suggest that in this sample, TXNIP does not play a major role in FCHL or related traits, and is unlikely to account for the positive evidence of linkage in this region.",
keywords = "Association, FCHL, Hyperlipidemia, Linkage, TXNIP",
author = "Hilary Coon and Nanda Singh and Diane Dunn and Eckfeldt, {John H.} and Province, {Michael A.} and Hopkins, {Paul N.} and Robert Weiss and Steven Hunt and Leppert, {Mark F.}",
year = "2004",
month = "6",
doi = "10.1016/j.atherosclerosis.2004.02.004",
language = "English",
volume = "174",
pages = "357--362",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study

AU - Coon, Hilary

AU - Singh, Nanda

AU - Dunn, Diane

AU - Eckfeldt, John H.

AU - Province, Michael A.

AU - Hopkins, Paul N.

AU - Weiss, Robert

AU - Hunt, Steven

AU - Leppert, Mark F.

PY - 2004/6

Y1 - 2004/6

N2 - Familial combined hyperlipidemia (FCHL) is the most common familial dyslipidemia, and is implicated in up to 20% of cases of premature coronary heart disease. Positive linkage to chromosome 1q was found in FCHL families participating in the NHLBI Family Heart Study (FHS), replicating linkage found in other studies. The HcB-19 mouse, which shares phenotypes with FCHL, was shown in other studies to have a nonsense mutation in the thioredoxin interacting protein gene (txnip). txnip is a gene on mouse chromosome 3 in a region syntenic with the 1q human FCHL linkage region. We re-sequenced the human homolog of mouse txnip in the FHS sample and identified nine single nucleotide polymorphisms (SNPs). We did not observe the nonsense mutation found in the HcB-19 mouse, and only three of the SNPs discovered were sufficiently polymorphic for analysis. No association between FCHL and the TXNIP gene was found. Within FCHL cases, presence of variants also did not significantly affect body mass index or levels of lipids, insulin, or glucose. Our results suggest that in this sample, TXNIP does not play a major role in FCHL or related traits, and is unlikely to account for the positive evidence of linkage in this region.

AB - Familial combined hyperlipidemia (FCHL) is the most common familial dyslipidemia, and is implicated in up to 20% of cases of premature coronary heart disease. Positive linkage to chromosome 1q was found in FCHL families participating in the NHLBI Family Heart Study (FHS), replicating linkage found in other studies. The HcB-19 mouse, which shares phenotypes with FCHL, was shown in other studies to have a nonsense mutation in the thioredoxin interacting protein gene (txnip). txnip is a gene on mouse chromosome 3 in a region syntenic with the 1q human FCHL linkage region. We re-sequenced the human homolog of mouse txnip in the FHS sample and identified nine single nucleotide polymorphisms (SNPs). We did not observe the nonsense mutation found in the HcB-19 mouse, and only three of the SNPs discovered were sufficiently polymorphic for analysis. No association between FCHL and the TXNIP gene was found. Within FCHL cases, presence of variants also did not significantly affect body mass index or levels of lipids, insulin, or glucose. Our results suggest that in this sample, TXNIP does not play a major role in FCHL or related traits, and is unlikely to account for the positive evidence of linkage in this region.

KW - Association

KW - FCHL

KW - Hyperlipidemia

KW - Linkage

KW - TXNIP

UR - http://www.scopus.com/inward/record.url?scp=2342530962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342530962&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2004.02.004

DO - 10.1016/j.atherosclerosis.2004.02.004

M3 - Article

VL - 174

SP - 357

EP - 362

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -